Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Melanoma × Rituximab × Clear all

Phase

Phase 2 2 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 60 Lymphoma 53 Lymphoma, Large B-Cell, Diffuse 51 Lymphoma, Non-Hodgkin 47 Lymphoma, Follicular 39 Lymphoma, Mantle-Cell 29 Lymphoma, B-Cell, Marginal Zone 25 Lymphoma, B-Cell 25 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Leukemia 19 Burkitt Lymphoma 19 Waldenstrom Macroglobulinemia 16 Recurrence 14 Hodgkin Disease 13 Multiple Myeloma 9 Lymphoma, Large-Cell, Immunoblastic 9 Leukemia, Myeloid, Acute 7 Hematologic Neoplasms 7 Neoplasms, Plasma Cell 6 Myelodysplastic Syndromes 6 Leukemia, Prolymphocytic 6 Neoplasms 5 Intraocular Lymphoma 5 Lymphoma, T-Cell 4 Leukemia, Hairy Cell 4 Myeloproliferative Disorders 3 Lymphoma, T-Cell, Peripheral 3 Leukemia, Myeloid, Chronic-Phase 3 Leukemia, B-Cell 3 Neoplasm Metastasis 2

Interventions

pembrolizumab 82 Nivolumab 50 Ipilimumab 50 Cyclophosphamide 50 fludarabine 25 Vemurafenib 24 aldesleukin 23 Interleukin-2 23 trametinib 19 fludarabine phosphate 19 dabrafenib 15 Biopsy 14 Temozolomide 13 Cisplatin 12 atezolizumab 11 spartalizumab 10 Introns 10 poly ICLC 9 cobimetinib 9 Specimen Handling 9 Radiosurgery 9 MART-1 Antigen 9 Carboplatin 9 incomplete Freund's adjuvant 8 Radiotherapy 8 Radiation 8 Paclitaxel 8 Magnetic Resonance Spectroscopy 8 Filgrastim 8 Docetaxel 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01032122 2013-04-25

Rituximab in Metastatic Melanoma

Medical University of Vienna

Phase 1 Terminated

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡